Call-To-Action Title
Virtual Press Conference: First COVID-19 Vaccine - 12/12/2020
As part of the FDA’s commitment to transparency, we invite you to watch our virtual press conference, recorded on December 12, 2020.
Learn MoreFDA Covid-19 Response
FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Dec 09
Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Anagrelide Capsules, USP Due to Dissolution Test Failure
Drugs
Dec 09
AvKARE Issues Voluntary Nationwide Recall of Sildenafil 100mg Tablets and Trazodone 100mg Tablets Due to Product Mix-Up
Drugs
Dec 07
George DeLallo Co., Inc. Issues Allergy Alert on Undeclared Pecans in 20 oz Publix Bakery Holiday Cookie Platters
Food & Beverages
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Project Orbis: Strengthening International Collaboration for Oncology Product Reviews, Faster Patient Access to Innovative Therapies
Project Orbis has demonstrated that global regulatory collaboration is attainable and can deliver faster access to new therapies for patients with cancer.
World AIDS Day 2020: FDA Continues to Drive Advances in Care and Work with the Global Public Health Community
Each year countless organizations and individuals around the world observe World AIDS Day – December 1 – to bring attention to the HIV epidemic.
Why the United States-Mexico-Canada Agreement is Important to FDA
How the many provisions in the United States-Mexico-Canada Agreement affect FDA, advance public health and FDA’s regulatory approaches.
Recently Published Guidances
Dec 11
Magnetic Resonance (MR) Receive-only Coil - Performance Criteria for Safety and Performance Based Pathway
Medical Devices, Radiation-Emitting Products
Dec 11
Spinal Plating Systems - Performance Criteria for Safety and Performance Based Pathway
Medical Devices
Dec 11
CVM GFI #262 Pre-Submission Consultation Process for Animal Food Additive Petitions or Generally Recognized as Safe (GRAS) Notices
Animal & Veterinary

